Martin Van Trieste, PHR '83 Presented the 2020 Sprowls Lecture

On Tuesday, March 24, Martin VanTrieste, PHR ’83 virtually presented What You Need to Know About Pharmaceutical Economics as the 2020 Sprowls Lecture to 178 guests.

Martin is CEO and Founder of Civica Rx, a nonprofit organization that is actively working to reduce the United States' reliance on overseas sources of medications - an initiative that is now more important than ever. Civica Rx was recently discussed by health policy experts in a Senate hearing about addressing challenges in the United States’ generic drug supply chain, especially in times of emergencies like COVID-19. 

Martin came out of retirement from a 35-plus year career in the pharmaceutical industry so that he could run Civica Rx. His previous role was senior vice president of quality at Amgen. He also held leadership roles in quality, operations, compliance, and research for Bayer and Abbott.

A number of organizations have recognized Martin for his contributions to the pharmaceutical industry. In 2019, Martin was number 37 on Modern Healthcare’s list of “100 Most Influential People in Healthcare.” The Medicine Maker named him one of the most influential people in the world of drug development and manufacturing in 2016, 2017 and 2018.

Martin embodies what it means to be Temple Made, to take on some of the most complex responsibilities readily, graciously, and ably. 

The Sprowls Lecture honors Dean Joseph B. Sprowls (served 1950–1967) for his many contributions to our school, university and profession. The Temple University School of Pharmacy and the School of Pharmacy Alumni Association present the Sprowls Lecture Award annually to an outstanding individual who has achieved recognition within pharmacy for significant contributions to the profession as a distinguished practitioner, scientist or educator.